Newly identified biomarker panel can help assess risk of chronic kidney disease progression in children

by

Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children. Their findings are published in the Journal of the American Society of Nephrology.

Leave A Comment

Your email address will not be published. Required fields are marked *